May 14, 2009

Oncolytics Biotech(R) Inc.'s Research Collaborators to Present Data on REOLYSIN(R) Clinical Trials at ASCO Conference

May 12, 2009

Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study

May 5, 2009

Oncolytics Biotech(R) Inc. Announces 2009 First Quarter Results

Feb 5, 2009

Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering North America

Feb 4, 2009

Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration

Jan 27, 2009

Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer

Jan 13, 2009

Oncolytics Biotech Inc. Announces Issuance of 31st U.S. Patent

Dec 22, 2008

Oncolytics Biotech Inc. Appoints Dr. Matt Coffey as Chief Operating Officer

Dec 18, 2008

Oncolytics Biotech Inc. Amends Terms of Previously Issued Broker Warrants

Dec 18, 2008

Oncolytics Biotech Inc. Completes Patient Enrolment in Two U.K. REOLYSIN(R) Combination Therapy Clinical Trials